期刊
MOLECULAR NUTRITION & FOOD RESEARCH
卷 66, 期 21, 页码 -出版社
WILEY
DOI: 10.1002/mnfr.202101019
关键词
ellagitannins; gut microbiota; metabotype; polyphenol; urolithins
资金
- Ministry of Science and Innovation (MICINN, Spain) [PID2019-103914RB-I00]
- Fundacion Seneca de la Region de Murcia, Spain [20880/PI/18, 19900/GERM/15]
- Standard European Marie Curie Fellowship from the European Commission
- European Union [838991]
- Marie Curie Actions (MSCA) [838991] Funding Source: Marie Curie Actions (MSCA)
Urolithins, metabolites produced by the gut microbiota from polyphenols, have been extensively studied for their potential health benefits. Recent research has identified 13 urolithins and their corresponding conjugated metabolites in various human fluids and tissues. The study highlights the importance of understanding the microorganisms involved in urolithin production and the composition of gut microbiota associated with urolithin metabolism. However, further in vitro studies are needed to confirm the reported activities of urolithins.
Urolithins, metabolites produced by the gut microbiota from the polyphenols ellagitannins and ellagic acid, are discovered by the research group in humans almost 20 years ago. Pioneering research suggests urolithins as pleiotropic bioactive contributors to explain the health benefits after consuming ellagitannin-rich sources (pomegranates, walnuts, strawberries, etc.). Here, this study comprehensively updates the knowledge on urolithins, emphasizing the review of the literature published during the last 5 years. To date, 13 urolithins and their corresponding conjugated metabolites (glucuronides, sulfates, etc.) have been described and, depending on the urolithin, detected in different human fluids and tissues (urine, blood, feces, breastmilk, prostate, colon, and breast tissues). There has been a substantial advance in the research on microorganisms involved in urolithin production, along with the compositional and functional characterization of the gut microbiota associated with urolithins metabolism that gives rise to the so-called urolithin metabotypes (UM-A, UM-B, and UM-0), relevant in human health. The design of in vitro studies using physiologically relevant assay conditions (molecular forms and concentrations) is still a pending subject, making some reported urolithin activities questionable. In contrast, remarkable progress has been made in the research on the safety, bioactivity, and associated mechanisms of urolithin A, including the first human interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据